InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Cruse Michael, Vice-Président Senior. Officer active across 1 company, notably Reneo Pharmaceuticals, Inc.. In total, 6 reports have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €57k. Activity tracked since 25 August 2021. The latest transaction was disclosed on 1 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
7,500 shares@ US$3.39344.5% of flowCommon StockSEC:0001209191-22-048534:0
Ideal exit: 29 May 2023 (T+270)
83 shares@ US$3.240.5% of flowCommon StockSEC:0001209191-22-048167:0
Ideal exit: 26 May 2023 (T+270)
25,000 shares0Common StockSEC:0001209191-21-069436:0
25,000 shares0Common StockSEC:0001209191-21-069436
2,500 shares@ US$7.446427.5% of flowCommon StockSEC:0001209191-21-053520
Ideal exit: 22 May 2022 (T+270)
2,500 shares@ US$7.446450.0% of flowCommon StockSEC:0001209191-21-053520:0
Ideal exit: 22 May 2022 (T+270)
6 of 6 declarations
About Cruse Michael
Cruse Michael is the Senior Vice President of Corporate Operations at Reneo Pharmaceuticals, Inc. He is responsible for managing operations and optimizing processes within the company. His role is essential to ensure that Reneo achieves its strategic and operational objectives while maintaining a high level of quality in its services.
